We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 331 results
  1. Integrative opioid-GABAergic neuronal mechanisms regulating dopamine efflux in the nucleus accumbens of freely moving animals

    The nucleus accumbens (NAc) is a terminal region of mesocorticolimbic dopamine (DA) neuronal projections from the ventral tegmental area. Accumbal DA...

    Tadashi Saigusa, Yuri Aono, John L. Waddington in Pharmacological Reports
    Article 20 March 2021
  2. Further proof on the role of accumbal nNOS in cocaine-seeking behavior in rats

    Background

    Cocaine use disorder (CUD) remains a severe health problem with no effective pharmacological therapy. One of the potential pharmacological...

    Małgorzata Frankowska, Irena Smaga, ... Małgorzata Filip in Pharmacological Reports
    Article 14 March 2024
  3. Network analysis of monoamines involved in anxiety-like behavior in a rat model of osteoarthritis

    Background

    Chronic pain is a major health problem that affects a significant number of patients, resulting in personal suffering and substantial...

    Jakub Mlost, Magdalena Białoń, ... Katarzyna Starowicz in Pharmacological Reports
    Article Open access 05 January 2024
  4. The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents

    Novel psychoactive substances (NPSs) are new psychotropic drugs designed to evade substance regulatory policies. 25E-NBOMe...

    Young-Jung Kim, Wun-A Kook, ... Choon-Gon Jang in Archives of Pharmacal Research
    Article 29 March 2024
  5. Treatment with dopamine β-hydroxylase (DBH) inhibitors prevents morphine use and relapse-like behavior in rats

    Background

    Opioid use disorders are serious contributors to the harms associated with the drug use. Unfortunately, therapeutic interventions for...

    Małgorzata Frankowska, Paulina Surówka, ... Patrycja Kleczkowska in Pharmacological Reports
    Article Open access 08 July 2021
  6. Identification of genes regulated by trait sensitivity to negative feedback and prolonged alcohol consumption in rats

    Background

    The results of our previous studies demonstrated that low sensitivity to negative feedback (NF) is associated with increased vulnerability...

    Agata Cieslik-Starkiewicz, Karolina Noworyta, ... Rafal Rygula in Pharmacological Reports
    Article Open access 03 January 2024
  7. Amphetamine-induced prolonged disturbances in tissue levels of dopamine and serotonin in the rat brain

    Background

    A hallmark of psychostimulants is the persistence of neurobiological changes they produce. The difficulty in reversing long-time effects of...

    Ewa Taracha, Magdalena Czarna, ... Piotr Maciejak in Pharmacological Reports
    Article Open access 21 March 2023
  8. The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons

    The role of adenosine A2A receptor (A2AR) and striatal-enriched protein tyrosine phosphatase (STEP) interactions in the striatal-pallidal GABA...

    Dasiel O. Borroto-Escuela, Luca Ferraro, ... Kjell Fuxe in Pharmacological Reports
    Article Open access 24 August 2021
  9. Orexin type-2 receptor blockade prevents the nicotine-induced excitation of nucleus accumbens core neurons in rats: An electrophysiological perspective

    Background

    The nucleus accumbens core (NAcc) expresses both orexin and nicotinic acetylcholine receptors (nAChRs). Orexin is among important...

    Reza Fartootzadeh, Fatemeh Azizi, ... Parham Reisi in Pharmacological Reports
    Article 31 December 2018
  10. Maternal feeding patterns affect the offspring’s brain: focus on serotonin 5-HT2C and 5-HT2A receptors

    Background

    Recent studies have shown a relationship between the composition of the maternal diet and acquiring a risk of mental illnesses through...

    Kinga Gawlińska, Dawid Gawliński, ... Edmund Przegaliński in Pharmacological Reports
    Article Open access 19 June 2021
  11. Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential

    The brain orchestrates whole-body metabolism through an intricate system involving interneuronal crosstalk and communication. Specifically, a key...

    Kimberly W. Y. Mak, Aws F. Mustafa, Denise D. Belsham in Pharmacological Reports
    Article 09 September 2022
  12. Ethanol deprivation and central 5-HT deficiency differentially affect the mRNA editing of the 5-HT2C receptor in the mouse brain

    Background

    Serotonin (5-HT) 5-HT 2C receptor mRNA editing (at five sites, A–E), implicated in neuropsychiatric disorders, including clinical...

    Magdalena Zaniewska, Natalia Alenina, ... Michael Bader in Pharmacological Reports
    Article Open access 03 November 2023
  13. Escitalopram alters local expression of noncanonical stress-related neuropeptides in the rat brain via NPS receptor signaling

    Background

    Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are...

    Aneta Piwowarczyk-Nowak, Artur Pałasz, ... John J. Worthington in Pharmacological Reports
    Article 02 June 2022
  14. Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs

    Metabotropic glutamate receptors (mGluRs) are part of the G protein-coupled receptors (GPCRs) family. They are coupled to G αq (group I) or G i/o ...

    Katarzyna Stachowicz in Pharmacological Reports
    Article Open access 28 June 2024
  15. The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission

    Background

    Despite our poor understanding of the pathophysiology of depression, a growing body of evidence indicates the role of both glutamate and...

    Gabriela Starowicz, Dominika Siodłak, ... Katarzyna Mlyniec in Pharmacological Reports
    Article Open access 30 March 2023
  16. Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia

    Background

    Alterations of dopamine D 1 (D1R) and D 2 receptor (D2R) are proposed in schizophrenia but brain neuroimaging and postmortem studies have...

    Iker Egusquiza, Eva Munarriz-Cuezva, ... Rebeca Diez-Alarcia in Pharmacological Reports
    Article Open access 01 July 2021
  17. Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain

    Background

    Several studies strongly support the role of the dopamine D 2 -like and glutamate mGlu 5 receptors in psychostimulant reward and relapse.

    ...
    Małgorzata Frankowska, Joanna Miszkiel, ... Małgorzata Filip in Pharmacological Reports
    Article 07 May 2019
  18. N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research

    Substance use disorder (SUD) is a chronic brain condition, with compulsive and uncontrollable drug-seeking that leads to long-lasting and harmful...

    Irena Smaga, Małgorzata Frankowska, Małgorzata Filip in Pharmacological Reports
    Article Open access 06 June 2021
  19. Pharmacologic hyperreactivity of kappa opioid receptors in periaqueductal gray matter during alcohol withdrawal syndrome in rats

    Background

    Periaqueductal gray matter (PAG) is a brain region rich in kappa-opioid receptors (KOR). KOR in PAG mediates behavioral responses related...

    Priscila Vázquez-León, Abraham Miranda-Páez, ... Bruno A. Marichal-Cancino in Pharmacological Reports
    Article 02 September 2023
  20. Adaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT2A receptors

    Background

    There is a strong support for the role of serotonin (5-HT) neurotransmission in depression and in the mechanism of action of...

    Dawid Gawliński, Irena Smaga, ... Małgorzata Filip in Pharmacological Reports
    Article 21 May 2019
Did you find what you were looking for? Share feedback.